Muna Bhanji

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Muna Bhanji
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Muna Bhanji:

Company Role Class Num Shares Value Price $ Report Date Ownership
VERACYTE, INC. Director Common Stock 39,310 $1,132,521 $28.81 18 Jun 2025 Direct
CYTOKINETICS INC Director Common Stock 23,510 $698,952 $29.73 15 May 2025 Direct
ARDELYX, INC. Director Common Stock 137,353 $543,917 $3.96 18 Jun 2025 Direct
Intellia Therapeutics, Inc. Director Common Stock 27,203 $226,328 $8.32 11 Jun 2025 Direct
ARDELYX, INC. Director Stock Option (Right to Buy) 54,059 $93,364 $2.32 18 Jun 2025 Direct
Intellia Therapeutics, Inc. Director Stock Option (right to buy) 11,450 11 Jun 2025 Direct
CYTOKINETICS INC Director Non-Qualified Stock Option (Right to Buy) 10,880 14 May 2025 Direct
CYTOKINETICS INC Director Non-Qualified Stock Option (Right to Buy) 3,636 15 May 2024 Direct

Insider Reports Filed by Muna Bhanji

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARDX ARDELYX, INC. 18 Jun 2025 2 $0 4 Director 23 Jun 2025, 20:39
VCYT VERACYTE, INC. 18 Jun 2025 1 $0 4 Director 23 Jun 2025, 16:09
VCYT VERACYTE, INC. 13 Jun 2025 1 -$122,366 4 Director 17 Jun 2025, 16:21
NTLA Intellia Therapeutics, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:27
CYTK CYTOKINETICS INC 15 May 2025 1 -$43,227 4 Director 15 May 2025, 18:51
CYTK CYTOKINETICS INC 14 May 2025 2 $0 4 Director 14 May 2025, 19:42
NTLA Intellia Therapeutics, Inc. 29 Apr 2025 1 -$2,252 4 Director 01 May 2025, 16:24
NTLA Intellia Therapeutics, Inc. 29 Jan 2025 1 -$2,642 4 Director 31 Jan 2025, 16:17
ARDX ARDELYX, INC. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 18:53
VCYT VERACYTE, INC. 13 Jun 2024 1 $0 4 Director 17 Jun 2024, 16:48
NTLA Intellia Therapeutics, Inc. 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 16:18
VCYT VERACYTE, INC. 10 Jun 2024 1 -$78,633 4 Director 11 Jun 2024, 16:22
CYTK CYTOKINETICS INC 10 Jun 2024 1 -$104,140 4 Director 10 Jun 2024, 16:15
VCYT VERACYTE, INC. 28 May 2024 1 -$32,319 4 Director 30 May 2024, 16:41
CYTK CYTOKINETICS INC 15 May 2024 2 $0 4 Director 16 May 2024, 18:17
NTLA Intellia Therapeutics, Inc. 31 Oct 2023 1 -$6,333 4 Director 02 Nov 2023, 16:42
NTLA Intellia Therapeutics, Inc. 31 Jul 2023 1 -$11,217 4 Director 02 Aug 2023, 17:19
CYTK CYTOKINETICS INC 07 Jul 2023 1 -$68,234 4 Director 07 Jul 2023, 16:17
NTLA Intellia Therapeutics, Inc. 06 Jul 2023 1 -$73,373 4 Director 10 Jul 2023, 17:21
VCYT VERACYTE, INC. 16 Jun 2023 2 -$155,785 4 Director 21 Jun 2023, 16:55
ARDX ARDELYX, INC. 15 Jun 2023 1 $0 4 Director 16 Jun 2023, 18:32
NTLA Intellia Therapeutics, Inc. 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:24
VCYT VERACYTE, INC. 09 Jun 2023 1 $0 4 Director 13 Jun 2023, 17:21
VCYT VERACYTE, INC. 30 May 2023 1 -$39,875 4 Director 01 Jun 2023, 17:06
CYTK CYTOKINETICS INC 10 May 2023 2 $0 4 Director 18 May 2023, 16:33
CYTK CYTOKINETICS INC 03 Oct 2022 1 $11,244 4 Director 05 Oct 2022, 16:18
CYTK CYTOKINETICS INC 01 Jul 2022 1 $11,234 4 Director 12 Jul 2022, 16:08
VCYT VERACYTE, INC. 16 Jun 2022 1 $0 4 Director 16 Jun 2022, 20:12
ARDX ARDELYX, INC. 15 Jun 2022 2 $0 4 Director 17 Jun 2022, 16:21
NTLA Intellia Therapeutics, Inc. 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 18:19
CYTK CYTOKINETICS INC 10 May 2022 2 $0 4 Director 11 May 2022, 18:04
NTLA Intellia Therapeutics, Inc. 28 Apr 2022 2 $0 4 Director 02 May 2022, 21:49
NTLA Intellia Therapeutics, Inc. 28 Apr 2022 0 $0 3 Director 02 May 2022, 21:48
CYTK CYTOKINETICS INC 01 Apr 2022 1 $11,245 4 Director 01 Apr 2022, 19:16
CYTK CYTOKINETICS INC 03 Jan 2022 1 $11,224 4 Director 04 Jan 2022, 15:46
CYTK CYTOKINETICS INC 12 May 2021 2 $0 4 Director 13 May 2021, 20:01